LCK and acute lymphoblastic leukemia: Interestingly, Dex treatment induces Lck phosphorylation at Y394, resulting in a profound activation of several downstream mediators (such as Fyn and ZAP70 kinases) in Jurkat T-ALL cells [44,105].